IGC-led research highlights anticancer drugs in sepsis treatment

11 jan 2023

Research led by the IGC reveals how these drugs limit inflammation, positioning them as potential treatments for sepsis. The study, published in eLife, reveals that this class of drugs used in cancer treatment limits the unrestrained production of inflammatory mediators by the immune system. The discovery positions these drugs as potential treatments for inflammatory diseases, such as sepsis, which kills as much as or more than oncologic disease.


Check the latest news about this initiative: 

Cookies settings

Cookies Selection

This website uses cookies to improve your browsing experience, security, and its website performance. We may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.